European prize for mobile vaccination units The Netherlands’ mobile vaccination units (prikbussen) have been selected as a best-practice method for the European project ‘Overcoming Obstacles to Vaccination’.
RIVM modelling for COVID-19 reviewed by international experts An international audit committee of scientific experts, commissioned by the RIVM Scientific Advisory Board, reviewed the institute’s COVID-19 data analytics and modelling work. These models and data formed a scientific basis for recommendations by the Outbreak Management Team (OMT) and others on COVID-19 control measures in the Netherlands.
Impact of coronavirus outbreak on participation in National Immunisation Programme limited Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).
Omicron subvariant BA.2 becomes dominant, decrease in hospital admissions Since this week, the Omicron subvariant BA.2 has caused the most infections in the Netherlands. 1,149 patients with a SARS-CoV-2 infection were admitted to hospital in the Netherlands in the past week*, a decrease of 18% compared to the week before t
Increase in COVID-19 hospital admissions, positive tests reaching high plateau Last week*, 1,266 patients with a SARS-CoV-2 infection were admitted to hospital in the Netherlands, an increase of 7% compared to the week before that.
Over half a million positive COVID-19 tests, more hospital admissions Last week*, 530,015 positive COVID-19 tests were reported to RIVM**. That is an increase of 45% compared to the week before that. The number of new hospital admissions rose by 11% in the past week. ICU admissions rose by 18%.